EGFR and lung adenocarcinoma: Supplementary analyses yielded consistent results.<h4>Conclusion</h4>The addition of definitive RT to first- or second-generation EGFR TKI treatment does not significantly improve OS of patients with EGFR-mutated stage IIIB or IIIC lung adenocarcinoma.